{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:01:49Z","timestamp":1782961309740,"version":"3.54.5"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Meridigen Biotech Co. Ltd.","award":["A-109-008"],"award-info":[{"award-number":["A-109-008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Surfactant therapy is a standard of care for preterm infants with respiratory distress and reduces the incidence of death and bronchopulmonary dysplasia in these patients. Our previous study found that mesenchymal stem cells (MSCs) attenuated hyperoxia-induced lung injury and the combination therapy of surfactant and human umbilical cord-derived MSCs (hUC-MSCs) did not have additive effects on hyperoxia-induced lung injury in neonatal rats. The aim is to evaluate the effects of 2 consecutive days of intratracheal administration of surfactant and hUC-MSCs on hyperoxia-induced lung injury.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Neonatal Sprague Dawley rats were reared in either room air (RA) or hyperoxia (85% O<jats:sub>2<\/jats:sub>) from postnatal days 1 to 14. On postnatal day 4, the rats received intratracheal injections of either 20\u2009\u03bcL of normal saline (NS) or 20\u2009\u03bcL of surfactant. On postnatal day 5, the rats reared in RA received intratracheal NS, and the rats reared in O<jats:sub>2<\/jats:sub> received intratracheal NS or hUC-MSCs (3\u2009\u00d7\u200910<jats:sup>4<\/jats:sup> or 3\u2009\u00d7\u200910<jats:sup>5<\/jats:sup> cells). Six study groups were examined: RA\u2009+\u2009NS\u2009+\u2009NS, RA\u2009+\u2009surfactant + NS, O<jats:sub>2<\/jats:sub>\u2009+\u2009NS\u2009+\u2009NS, O<jats:sub>2<\/jats:sub>\u2009+\u2009surfactant + NS, O<jats:sub>2<\/jats:sub>\u2009+\u2009surfactant + hUC-MSCs (3\u2009\u00d7\u200910<jats:sup>4<\/jats:sup> cells), and O<jats:sub>2<\/jats:sub>\u2009+\u2009surfactant + hUC-MSCs (3\u2009\u00d7\u200910<jats:sup>5<\/jats:sup> cells). The lungs were excised for histological, western blot, and cytokine analyses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The rats reared in hyperoxia and treated with NS yielded significantly higher mean linear intercepts (MLIs) and interleukin (IL)-1\u03b2 and IL-6 levels and significantly lower vascular endothelial growth factors (VEGFs), platelet-derived growth factor protein expression, and vascular density than did those reared in RA and treated with NS or surfactant. The lowered MLIs and cytokines and the increased VEGF expression and vascular density indicated that the surfactant and surfactant + hUC-MSCs (3\u2009\u00d7\u200910<jats:sup>4<\/jats:sup> cells) treatment attenuated hyperoxia-induced lung injury. The surfactant + hUC-MSCs (3\u2009\u00d7\u200910<jats:sup>5<\/jats:sup> cells) group exhibited a significantly lower MLI and significantly higher VEGF expression and vascular density than the surfactant + hUC-MSCs (3\u2009\u00d7\u200910<jats:sup>4<\/jats:sup> cells) group did.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Consecutive daily administration of intratracheal surfactant and hUC-MSCs can be an effective regimen for treating hyperoxia-induced lung injury in neonates.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-021-02335-4","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T11:43:03Z","timestamp":1620042183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats"],"prefix":"10.1186","volume":"12","author":[{"given":"Hsiu-Chu","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hsiang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8762-8957","authenticated-orcid":false,"given":"Chung-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,1]]},"reference":[{"issue":"12","key":"2335_CR1","doi-asserted-by":"publisher","first-page":"L948","DOI":"10.1152\/ajplung.00160.2014","volume":"307","author":"M O\u2019Reilly","year":"2014","unstructured":"O\u2019Reilly M, Th\u00e9baud B. Animal models of bronchopulmonary dysplasia. The term rat models. Am J Physiol Lung Cell Mol Physiol. 2014;307(12):L948\u201358. https:\/\/doi.org\/10.1152\/ajplung.00160.2014.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"2335_CR2","doi-asserted-by":"publisher","first-page":"L799","DOI":"10.1152\/ajplung.2001.281.4.L799","volume":"281","author":"JS Manji","year":"2001","unstructured":"Manji JS, O\u2019Kelly CJ, Leung WI, Olson DM. Timing of hyperoxic exposure during alveolarization influences damage mediated by leukotrienes. Am J Physiol Lung Cell Mol Physiol. 2001;281(4):L799\u2013806. https:\/\/doi.org\/10.1152\/ajplung.2001.281.4.L799.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"2335_CR3","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3389\/fimmu.2019.00681","volume":"10","author":"CM Chen","year":"2019","unstructured":"Chen CM, Hwang J, Chou HC. Maternal Tn immunization attenuates hyperoxia-induced lung injury in neonatal rats through suppression of oxidative stress and inflammation. Front Immunol. 2019;10:681. https:\/\/doi.org\/10.3389\/fimmu.2019.00681.","journal-title":"Front Immunol"},{"issue":"3","key":"2335_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/MOP.0b013e328346577f","volume":"23","author":"J Gien","year":"2011","unstructured":"Gien J, Kinsella JP. Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr. 2011;23(3):305\u201313. https:\/\/doi.org\/10.1097\/MOP.0b013e328346577f.","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"2335_CR5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1542\/peds.2008-0862","volume":"123","author":"M Laughon","year":"2009","unstructured":"Laughon M, Allred EN, Bose C, O'Shea TM, Van Marter LJ, Ehrenkranz RA, et al. ELGAN study investigators. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics. 2009;123(4):1124\u201331. https:\/\/doi.org\/10.1542\/peds.2008-0862.","journal-title":"Pediatrics."},{"issue":"1","key":"2335_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1542\/peds.2013-3443","volume":"133","author":"RA Polin","year":"2014","unstructured":"Polin RA, Carlo WA. Committee on Fetus and Newborn, American Academy of Pediatrics. Surfactant replacement therapy for preterm and term neonates with respiratory distress. Pediatrics. 2014;133(1):156\u201363. https:\/\/doi.org\/10.1542\/peds.2013-3443.","journal-title":"Pediatrics."},{"issue":"11-12","key":"2335_CR7","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3727\/096368911X565038a","volume":"20","author":"YS Chang","year":"2011","unstructured":"Chang YS, Choi SJ, Sung DK, Kim SY, Oh W, Yang YS, Park WS. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats. Cell Transplant. 2011;20(11-12):1843\u201354. https:\/\/doi.org\/10.3727\/096368911X565038a.","journal-title":"Cell Transplant"},{"issue":"15","key":"2335_CR8","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1089\/scd.2010.0566","volume":"21","author":"P Waszak","year":"2012","unstructured":"Waszak P, Alphonse R, Vadivel A, Ionescu L, Eaton F, Th\u00e9baud B. Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats. Stem Cells Dev. 2012;21(15):2789\u201397. https:\/\/doi.org\/10.1089\/scd.2010.0566.","journal-title":"Stem Cells Dev"},{"issue":"9","key":"2335_CR9","doi-asserted-by":"publisher","first-page":"L829","DOI":"10.1152\/ajplung.00347.2011","volume":"302","author":"KA Tropea","year":"2012","unstructured":"Tropea KA, Leder E, Aslam M, Lau AN, Raiser DM, Lee JH, Balasubramaniam V, Fredenburgh LE, Alex Mitsialis S, Kourembanas S, Kim CF. Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2012;302(9):L829\u201337. https:\/\/doi.org\/10.1152\/ajplung.00347.2011.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"issue":"5","key":"2335_CR10","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1136\/thoraxjnl-2012-202323","volume":"68","author":"M Pierro","year":"2013","unstructured":"Pierro M, Ionescu L, Montemurro T, Vadivel A, Weissmann G, Oudit G, Emery D, Bodiga S, Eaton F, P\u00e9ault B, Mosca F, Lazzari L, Th\u00e9baud B. Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax. 2013;68(5):475\u201384. https:\/\/doi.org\/10.1136\/thoraxjnl-2012-202323.","journal-title":"Thorax."},{"issue":"1","key":"2335_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/pr.2012.152","volume":"73","author":"RP Sutsko","year":"2013","unstructured":"Sutsko RP, Young KC, Ribeiro A, Torres E, Rodriguez M, Hehre D, Devia C, McNiece I, Suguihara C. Long-term reparative effects of mesenchymal stem cell therapy following neonatal hyperoxia-induced lung injury. Pediatr Res. 2013;73(1):46\u201353. https:\/\/doi.org\/10.1038\/pr.2012.152.","journal-title":"Pediatr Res"},{"key":"2335_CR12","first-page":"342","volume":"8","author":"HC Chou","year":"2016","unstructured":"Chou HC, Li YT, Chen CM. Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia. Am J Transl Res. 2016;8:342\u201353.","journal-title":"Am J Transl Res"},{"issue":"8","key":"2335_CR13","first-page":"2628","volume":"10","author":"CM Chen","year":"2018","unstructured":"Chen CM, Chou HC. Human mesenchymal stem cells attenuate hyperoxia-induced lung injury through inhibition of the renin-angiotensin system in newborn rats. Am J Transl Res. 2018;10(8):2628\u201335.","journal-title":"Am J Transl Res"},{"issue":"1","key":"2335_CR14","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13287-017-0634-y","volume":"8","author":"CM Chen","year":"2017","unstructured":"Chen CM, Chou HC, Lin W, Tseng C. Surfactant effects on the viability and function of human mesenchymal stem cells: in vitro and in vivo assessment. Stem Cell Res Ther. 2017;8(1):180. https:\/\/doi.org\/10.1186\/s13287-017-0634-y.","journal-title":"Stem Cell Res Ther"},{"key":"2335_CR15","first-page":"CD001456","volume":"11","author":"FL Bahadue","year":"2012","unstructured":"Bahadue FL, Soll R. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome. Cochrane Database Syst Rev. 2012;11:CD001456.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2335_CR16","doi-asserted-by":"publisher","first-page":"e52419","DOI":"10.1371\/journal.pone.0052419","volume":"8","author":"YS Chang","year":"2013","unstructured":"Chang YS, Choi SJ, Ahn SY, Sung DK, Sung SI, Yoo HS, Oh WI, Park WS. Timing of umbilical cord blood derived mesenchymal stem cells transplantation determines therapeutic efficacy in the neonatal hyperoxic lung injury. PLoS One. 2013;8(1):e52419. https:\/\/doi.org\/10.1371\/journal.pone.0052419.","journal-title":"PLoS One"},{"key":"2335_CR17","first-page":"e61117","volume":"159","author":"CM Chen","year":"2020","unstructured":"Chen CM, Chen YJ, Huang ZH. Intratracheal instillation of stem cells in term neonatal rats. J Vis Exp. 2020;159:e61117.","journal-title":"J Vis Exp"},{"issue":"6","key":"2335_CR18","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.3892\/ijmm.2017.3171","volume":"40","author":"B Pan","year":"2017","unstructured":"Pan B, Xue X, Zhang D, Li M, Fu J. SOX4 arrests lung development in rats with hyperoxia-induced bronchopulmonary dysplasia by controlling EZH2 expression. Int J Mol Med. 2017;40(6):1691\u20138. https:\/\/doi.org\/10.3892\/ijmm.2017.3171.","journal-title":"Int J Mol Med"},{"issue":"4","key":"2335_CR19","doi-asserted-by":"publisher","first-page":"L941","DOI":"10.1152\/ajplung.00054.2007","volume":"293","author":"D Irwin","year":"2007","unstructured":"Irwin D, Helm K, Campbell N, Imamura M, Fagan K, Harral J, Carr M, Young KA, Klemm D, Gebb S, Dempsey EC, West J, Majka S. Neonatal lung side population cells demonstrate endothelial potential and are altered in response to hyperoxia-induced lung simplification. Am J Physiol Lung Cell Mol Physiol. 2007;293(4):L941\u201351. https:\/\/doi.org\/10.1152\/ajplung.00054.2007.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"issue":"5","key":"2335_CR20","doi-asserted-by":"publisher","first-page":"L1101","DOI":"10.1152\/ajplung.00126.2006","volume":"291","author":"M Yee","year":"2006","unstructured":"Yee M, Vitiello PF, Roper JM, Staversky RJ, Wright TW, McGrath-Morrow SA, et al. Type II epithelial cells are critical target for hyperoxia-mediated impairment of postnatal lung development. Am J Physiol Lung Cell Mol Physiol. 2006;291(5):L1101\u201311. https:\/\/doi.org\/10.1152\/ajplung.00126.2006.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"issue":"1","key":"2335_CR21","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12931-016-0453-1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Yue S, Luo Z, Cao C, Yu X, Liao Z, Wang MJ. N-methyl-D-aspartate receptor activation mediates lung fibroblast proliferation and differentiation in hyperoxia-induced chronic lung disease in newborn rats. Respir Res. 2016;17(1):136. https:\/\/doi.org\/10.1186\/s12931-016-0453-1.","journal-title":"Respir Res"},{"issue":"2-3","key":"2335_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0925-4439(98)00060-X","volume":"1408","author":"J Goerke","year":"1998","unstructured":"Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta. 1998;1408(2-3):79\u201389. https:\/\/doi.org\/10.1016\/S0925-4439(98)00060-X.","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"2335_CR23","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1136\/thx.2004.036699","volume":"60","author":"KB Reid","year":"2005","unstructured":"Reid KB, Clark H, Palaniyar N. Surfactant and lung inflammation. Thorax. 2005;60(8):620\u20132. https:\/\/doi.org\/10.1136\/thx.2004.036699.","journal-title":"Thorax."},{"issue":"12","key":"2335_CR24","doi-asserted-by":"publisher","first-page":"e51945","DOI":"10.1371\/journal.pone.0051945","volume":"7","author":"S Perveen","year":"2012","unstructured":"Perveen S, Patel H, Arif A, Younis S, Codipilly CN, Ahmed M. Role of EC-SOD overexpression in preserving pulmonary angiogenesis inhibited by oxidative stress. Plos One. 2012;7(12):e51945. https:\/\/doi.org\/10.1371\/journal.pone.0051945.","journal-title":"Plos One"},{"issue":"4","key":"2335_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1203\/01.PDR.0000155762.91748.8D","volume":"57","author":"X Zhang","year":"2005","unstructured":"Zhang X, Reinsvold P, Thibeault DW, Ekekezie II, Rezaiekhaligh M, Mabry SM, Buch S, Truog WE. Responses of pulmonary platelet-derived growth factor peptides and receptors to hyperoxia and nitric oxide in piglet lungs. Pediatr Res. 2005;57(4):523\u20139. https:\/\/doi.org\/10.1203\/01.PDR.0000155762.91748.8D.","journal-title":"Pediatr Res"},{"issue":"4","key":"2335_CR26","doi-asserted-by":"publisher","first-page":"L287","DOI":"10.1152\/ajplung.00229.2015","volume":"310","author":"EJ Yun","year":"2016","unstructured":"Yun EJ, Lorizio W, Seedorf G, Abman SH, Vu TH. VEGF and endothelium-derived retinoic acid regulate lung vascular and alveolar development. Am J Physiol Lung Cell Mol Physiol. 2016;310(4):L287\u201398. https:\/\/doi.org\/10.1152\/ajplung.00229.2015.","journal-title":"Am J Physiol Lung Cell Mol Physiol."},{"key":"2335_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-642-58456-5_4","volume":"93","author":"P Lindahl","year":"1999","unstructured":"Lindahl P, Bostr\u00f6m H, Karlsson L, Hellstr\u00f6m M, Kalen M, Betsholtz C. Role of platelet-derived growth factors in angiogenesis and alveogenesis. Curr Top Pathol. 1999;93:27\u201333. https:\/\/doi.org\/10.1007\/978-3-642-58456-5_4.","journal-title":"Curr Top Pathol"},{"issue":"6","key":"2335_CR28","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1183\/09031936.00032809","volume":"34","author":"E Gitto","year":"2009","unstructured":"Gitto E, Pellegrino S, D\u2019Arrigo S, Barberi I, Reiter RJ. Oxidative stress in resuscitation and in ventilation of newborns. Eur Respir J. 2009;34(6):1461\u20139. https:\/\/doi.org\/10.1183\/09031936.00032809.","journal-title":"Eur Respir J"},{"issue":"4","key":"2335_CR29","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1542\/peds.2008-0526","volume":"123","author":"N Ambalavanan","year":"2009","unstructured":"Ambalavanan N, Carlo WA, D\u2019Angio CT, McDonald SA, Das A, Schendel D, et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics. 2009;123(4):1132\u201341. https:\/\/doi.org\/10.1542\/peds.2008-0526.","journal-title":"Pediatrics."},{"issue":"1","key":"2335_CR30","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1164\/rccm.201409-1594OC","volume":"191","author":"PM Mourani","year":"2015","unstructured":"Mourani PM, Sontag MK, Younoszai A, Miller JI, Kinsella JP, Baker CD, Poindexter BB, Ingram DA, Abman SH. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2015;191(1):87\u201395. https:\/\/doi.org\/10.1164\/rccm.201409-1594OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"2335_CR31","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/jp.2016.250","volume":"37","author":"G Al-Ghanem","year":"2017","unstructured":"Al-Ghanem G, Shah P, Thomas S, Banfield L, El Helou S, Fusch C, et al. Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis. J Perinatol. 2017;37(4):414\u20139. https:\/\/doi.org\/10.1038\/jp.2016.250.","journal-title":"J Perinatol"},{"issue":"2","key":"2335_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4103\/2045-8932.97603","volume":"2","author":"G Hansmann","year":"2012","unstructured":"Hansmann G, Fernandez-Gonzalez A, Aslam M, Vitali SH, Martin T, Mitsialis SA, Kourembanas S. Mesenchymal stem cell-mediated reversal of bronchopulmonary dysplasia and associated pulmonary hypertension. Pulm Circ. 2012;2(2):170\u201381. https:\/\/doi.org\/10.4103\/2045-8932.97603.","journal-title":"Pulm Circ"},{"issue":"47","key":"2335_CR33","doi-asserted-by":"publisher","first-page":"82366","DOI":"10.18632\/oncotarget.19388","volume":"8","author":"CM Chen","year":"2017","unstructured":"Chen CM, Lin W, Huang LT, Chou HC. Human mesenchymal stem cells ameliorate experimental pulmonary hypertension induced by maternal inflammation and neonatal hyperoxia in rats. Oncotarget. 2017;8(47):82366\u201375. https:\/\/doi.org\/10.18632\/oncotarget.19388.","journal-title":"Oncotarget."},{"issue":"11","key":"2335_CR34","doi-asserted-by":"publisher","first-page":"L1145","DOI":"10.1152\/ajplung.00039.2015","volume":"308","author":"I Mi\u017e\u00edkov\u00e1","year":"2015","unstructured":"Mi\u017e\u00edkov\u00e1 I, Ruiz-Camp J, Steenbock H, Madurga A, Vad\u00e1sz I, Herold S, Mayer K, Seeger W, Brinckmann J, Morty RE. Collagen and elastin cross-linking is altered during aberrant late lung development associated with hyperoxia. Am J Physiol Lung Cell Mol Physiol. 2015;308(11):L1145\u201358. https:\/\/doi.org\/10.1152\/ajplung.00039.2015.","journal-title":"Am J Physiol Lung Cell Mol Physiol."}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02335-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-021-02335-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-021-02335-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T06:03:43Z","timestamp":1626847423000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-021-02335-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2335"],"URL":"https:\/\/doi.org\/10.1186\/s13287-021-02335-4","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,1]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Animal Care and Use Committee at Taipei Medical University (LAC-2019-0396).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors are aware of and agree to the content of the paper and they are being listed as authors. There are no potential conflicts of interest exist with any company whose products were used in this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"258"}}